Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Anne Berger-Carbonne"'
Autor:
Colette Menard, Sophie Fégueux, Zoë Heritage, Michèle Nion-Huang, Anne Berger-Carbonne, Isabelle Bonmarin
Publikováno v:
Antimicrobial Resistance and Infection Control, Vol 11, Iss 1, Pp 1-10 (2022)
Abstract Background During the last 20 years, France has taken important steps to tackle antibiotic resistance. These include national awareness campaigns for the general public, and supporting changes in terms of antibiotic prescription for healthca
Externí odkaz:
https://doaj.org/article/bcfbb741d85a4ff1b9d26cdc133b4efa
Autor:
Côme Daniau, Emmanuel Lecorche, Faiza Mougari, Hanaa Benmansour, Claude Bernet, Hervé Blanchard, Jérôme Robert, Anne Berger-Carbonne, Emmanuelle Cambau
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 3, Pp 518-526 (2022)
We describe nontuberculous mycobacteria (NTM) infections during 2012–2020 associated with health care and aesthetic procedures in France. We obtained epidemiologic data from the national early warning response system for healtcare-associated infect
Externí odkaz:
https://doaj.org/article/9944437c18b94727b7b14141770b9279
Autor:
Fabrice Compain, Dominique Decré, Isabelle Frazier, Astrid Ramahefasolo, Marie Lavollay, Etienne Carbonnelle, Hidayeth Rostane, Arzu Tackin, Anne Berger-Carbonne, Isabelle Podglajen
Publikováno v:
Emerging Infectious Diseases, Vol 20, Iss 7, Pp 1246-1248 (2014)
Externí odkaz:
https://doaj.org/article/299c1fcf60d644b4ba41430585064e0b
Autor:
Lecuru, Marion, Daniau, Côme, Alfandari, Serge, Dumartin, Catherine, Bajolet, Odile, Blanchard, Hervé, Simon, Loïc, Anne-Berger-Carbonne, Colomb-Cotinat, Mélanie
Publikováno v:
In Infectious Diseases Now October 2022 52(7):396-402
Autor:
Marion Lecuru, Côme Daniau, Serge Alfandari, Catherine Dumartin, Odile Bajolet, Hervé Blanchard, Loïc Simon, null Anne-Berger-Carbonne, Mélanie Colomb-Cotinat
Publikováno v:
Infectious Diseases Now. 52:396-402
Infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) remain a public health challenge.We traced the evolution of antibiotics prescribed for patients with ESBLE-healthcare associated infections (ESBLE-HAI) between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d6b6668dc849bed0e56af39db965638
https://doi.org/10.1016/j.idnow.2022.08.003
https://doi.org/10.1016/j.idnow.2022.08.003
Autor:
Colette, Menard, Sophie, Fégueux, Zoë, Heritage, Michèle, Nion-Huang, Anne, Berger-Carbonne, Isabelle, Bonmarin
Background During the last 20 years, France has taken important steps to tackle antibiotic resistance. These include national awareness campaigns for the general public, and supporting changes in terms of antibiotic prescription for healthcare practi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c67ddd1709d140d29e7e05b7621e106
https://doi.org/10.21203/rs.3.rs-1373746/v1
https://doi.org/10.21203/rs.3.rs-1373746/v1
Autor:
Anne Berger Carbonne, Stéphane Nardy
Publikováno v:
Les Tribunes de la santé. :73-80
En 2017, le rancongiciel WannaCry deferle sur l’Europe, impactant des dizaines de milliers d’entreprises privees et publiques. Le National Healthcare System (NHS), ministere de la Sante britannique, ainsi qu’une quinzaine d’hopitaux sont alor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::651a51ab2aeff2d82b7d3b92e33972e6
https://doi.org/10.3917/seve1.060.0073
https://doi.org/10.3917/seve1.060.0073
Autor:
Lecuru, Marion, Daniau, Côme, Alfandari, Serge, Dumartin, Catherine, Bajolet, Odile, Blanchard, Hervé, Simon, Loïc, Anne-Berger-Carbonne, Colomb-Cotinat, Mélanie
Publikováno v:
Infectious Diseases Now; October 2022, Vol. 52 Issue: 7 p396-402, 7p
Autor:
Mélanie, Colomb-Cotinat, Laetitia, Assouvie, Julien, Durand, Côme, Daniau, Lucie, Leon, Sylvie, Maugat, Sophan, Soing-Altrach, Cécile, Gateau, Jeanne, Couturier, Isabelle, Arnaud, Pascal, Astagneau, Anne, Berger-Carbonne, Frédéric, Barbut
Publikováno v:
Eurosurveillance
Background Clostridioides difficile is a leading cause of healthcare-associated diarrhoea in middle and high-income countries. Up to 2018, there has been no systematic, annual surveillance for C. difficile infections (CDI) in France. Aims To provide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::87e7141b1e3112aad4350481385e5b3b
https://pubmed.ncbi.nlm.nih.gov/31481147
https://pubmed.ncbi.nlm.nih.gov/31481147
Autor:
Isabelle Arnaud, Pascal Astagneau, Lucie Leon, Jeanne Couturier, Mélanie Colomb-Cotinat, Anne Berger-Carbonne, Sylvie Maugat, Cécile Gateau, Sophan Soing-Altrach, Côme Daniau, Frédéric Barbut, Laetitia Assouvie, Julien Durand
Publikováno v:
Eurosurveillance
Eurosurveillance, European Centre for Disease Prevention and Control, 2019, 24 (35), pp.7-16. ⟨10.2807/1560-7917.ES.2019.24.35.1800638⟩
Eurosurveillance, European Centre for Disease Prevention and Control, 2019, 24 (35), pp.7-16. ⟨10.2807/1560-7917.ES.2019.24.35.1800638⟩
Background Clostridioides difficile is a leading cause of healthcare-associated diarrhoea in middle and high-income countries. Up to 2018, there has been no systematic, annual surveillance for C. difficile infections (CDI) in France. Aims To provide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df1c81941ffb8cd1f3d035546b303cb5
https://doi.org/10.2807/1560-7917.es.2019.24.35.1800638
https://doi.org/10.2807/1560-7917.es.2019.24.35.1800638